The world needs a global plan to tackle antimicrobial resistance. Alongside a $2B fund to jump-start innovation there should be a $1B reward for companies when a new antibiotic is launched, says Jim O’Neill, chair of the review
To fight growing antimicrobial resistance, the use of existing antimicrobial drugs should be restricted, and there should be incentives for new ones should be developed
As the first World Antibiotics Awareness week has highlighted, the traditional business model for antibiotics is broken. Incentives are required to promote development of new products, says Luke Moore. What about a lump sum payment?
The rising tide of drug-resistant infections and dearth of new antibiotics calls for the same kind of urgency and action as the HIV/AIDs epidemic, says Laura Piddock, founder of Antibiotic Action
Following the deadly outbreak of E. coli infections in Germany, scientists in Saarbruecken are providing free access to the pathogen’s genetic regulation data, to spur research into new antibiotics
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.